TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Somnomed Limited ( (AU:SOM) ) has issued an announcement.
Somnomed Limited announced the issuance of unquoted equity securities as part of an employee incentive scheme. This issuance includes options with specific expiration dates and exercise prices, which are not immediately quoted on the ASX, indicating a strategic move to motivate and retain key personnel while potentially impacting future financial performance.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on the development and distribution of oral appliances for the treatment of sleep-related disorders. The company primarily provides solutions for obstructive sleep apnea and snoring, catering to a global market with its innovative products.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
Learn more about SOM stock on TipRanks’ Stock Analysis page.